0001990659-23-000001.txt : 20230824 0001990659-23-000001.hdr.sgml : 20230824 20230823202708 ACCESSION NUMBER: 0001990659-23-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20230824 DATE AS OF CHANGE: 20230823 EFFECTIVENESS DATE: 20230824 FILER: COMPANY DATA: COMPANY CONFORMED NAME: FORE US Bio Inc. CENTRAL INDEX KEY: 0001990659 IRS NUMBER: 920276296 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-490554 FILM NUMBER: 231198727 BUSINESS ADDRESS: STREET 1: 3675 MARKET STREET STREET 2: SUITE 200 CITY: PHILADELPHIA STATE: PA ZIP: 19104 BUSINESS PHONE: 267-641-7575 MAIL ADDRESS: STREET 1: 3675 MARKET STREET STREET 2: SUITE 200 CITY: PHILADELPHIA STATE: PA ZIP: 19104 D 1 primary_doc.xml X0708 D LIVE 0001990659 FORE US Bio Inc. 3675 MARKET STREET SUITE 200 PHILADELPHIA PA PENNSYLVANIA 19104 267-641-7575 DELAWARE None None Corporation true 2022 Matthew Ros 3675 Market Street Suite 200 Philadelphia PA PENNSYLVANIA 19104 Executive Officer Director Chief Executive Officer, President and Secretary Erez Chimovits 3675 Market Street Suite 200 Philadelphia PA PENNSYLVANIA 19104 Director Dieter Weinand 3675 Market Street Suite 200 Philadelphia PA PENNSYLVANIA 19104 Director Chandra Leo 3675 Market Street Suite 200 Philadelphia PA PENNSYLVANIA 19104 Director Matthew Foy 3675 Market Street Suite 200 Philadelphia PA PENNSYLVANIA 19104 Director Michal Silverberg 3675 Market Street Suite 200 Philadelphia PA PENNSYLVANIA 19104 Director Roberto De Ponti 3675 Market Street Suite 200 Philadelphia PA PENNSYLVANIA 19104 Director Meenu Chhabra Karson 3675 Market Street Suite 200 Philadelphia PA PENNSYLVANIA 19104 Director Kim Blackwell 3675 Market Street Suite 200 Philadelphia PA PENNSYLVANIA 19104 Director Jeff Sacher 3675 Market Street Suite 200 Philadelphia PA PENNSYLVANIA 19104 Executive Officer Chief Financial Officer Biotechnology Decline to Disclose 06b false 2023-08-09 false true false 0 122561289 62079394 60481895 $28,629,470.70 of the Total Offering Amount and Total Amount Sold includes principal and interest due on certain instruments convertible or exercisable into equity of the Issuer. false 20 0 0 0 false FORE US Bio Inc. Matthew Ros Matthew Ros CEO 2023-08-23